Microbot Medical (MBOT) Osake Kurssi
Microbot Medical Kurssi
Viimeisten 9 vuoden aikana Microbot Medicaln liikevaihto kasvoi 2,6 % vuodessa ja ylsi 117 000,00 USD:een. Microbot Medicaln nettomarginaali −31 123,9 % on laskenut verrattuna −1 746,8 %:iin muutama vuosi sitten. Microbot Medicaln 12 kuukauden konsensustavoitehinta on 4,00 USD, noin yli kurssia 257,1 %. 9 analyytikosta 8 suosittaa ostoa — kokonaiskonsensus on Osta.
Microbot Medical osakekurssi
Microbot Medical liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Microbot Medical -osakkeesta
Microbot Medical Inc's business model focuses on the development and commercialization of innovative transformational robotic solutions in the medical industry. The company specializes in creating miniature robots that can assist in minimally invasive surgeries, targeted drug delivery, and targeted endotherapy procedures. Microbot Medical Inc utilizes its proprietary technologies, including its Microbot Swarm system and ViRob robotic platform, to address critical unmet needs in various medical specialties. With its advanced robotic solutions, Microbot Medical Inc aims to improve patient outcomes, enhance surgical procedures, and provide physicians with more precise and efficient tools for diagnosis and treatment in the medical field.
Microbot Medical Inc is primarily active in the medical technology industry. As a cutting-edge company, Microbot Medical specializes in the development and commercialization of robotic technologies focused on improved medical procedures and treatments. With its innovative product portfolio, Microbot Medical aims to revolutionize various medical fields such as urology, neurology, and cardiovascular healthcare. Through its dedication to technological advancements and industry collaborations, Microbot Medical strives to provide healthcare professionals and patients with breakthrough solutions that enhance overall medical outcomes.
The main competitors of Microbot Medical Inc in the market include companies such as Medtronic, Intuitive Surgical, and Johnson & Johnson.
Microbot Medical Inc is a leading medical device company specializing in the development of transformational micro-robotic technologies. Established in 2010, Microbot Medical Inc aims to improve patient outcomes through the development of innovative robotic platforms designed for minimally invasive surgeries and targeted therapies. The company's cutting-edge technologies utilize advanced engineering and robotics to address significant unmet medical needs in various medical fields, including urology, gastroenterology, and ENT (ear, nose, and throat). With its commitment to revolutionizing medical interventions, Microbot Medical Inc continues to push boundaries in the field of robotic medicine, creating new possibilities for improved patient care.
Microbot Medical Inc has achieved several significant milestones. Firstly, the company successfully developed and received regulatory clearance for its innovative robotic technologies in the medical industry. Additionally, Microbot Medical Inc has made notable advancements in the fields of urology, neurology, and gastrointestinal procedures. The company has also successfully completed important clinical studies and collaborations with leading medical institutions. Moreover, Microbot Medical Inc has secured intellectual property rights for its proprietary technologies, which strengthens its position in the market. These milestones demonstrate the company's dedication to improving healthcare outcomes and solidify its reputation as a leader in the medical robotics field.
Microbot Medical Inc is primarily present in the United States, Israel, and Europe. This company, specializing in micro-robotics technologies, operates in multiple regions to distribute their innovative medical devices and solutions. Microbot Medical Inc's presence in these countries and regions enables them to reach a significant market and collaborate with leading medical institutions, professionals, and industry experts. By establishing a global footprint, Microbot Medical Inc aims to enhance patient outcomes and revolutionize the field of medical robotics.
Microbot Medical Inc represents values of innovation, advancement, and patient-centric healthcare solutions. With a strong corporate philosophy aimed at addressing unmet medical needs, Microbot Medical Inc is dedicated to developing and commercializing transformative robotic technologies. By combining novel engineering with medical expertise, the company aims to improve patient outcomes, reduce healthcare costs, and enhance overall quality of life. Microbot Medical Inc strives to empower physicians and healthcare professionals with cutting-edge tools and solutions, all while prioritizing patient safety and well-being.
Analyytikot asettavat tällä hetkellä Microbot Medical-osakkeelle keskimääräisen tavoitehinnan 4,00 USD (mediaani: 4,00 USD), mikä merkitsee +257,1 % viimeisimpään hintaan verrattuna. Konsensus perustuu 9 analyytikkoarvioon.
9 analyytikkoa arvioi tällä hetkellä Microbot Medical-osaketta: 8 suosittaa ostoa, 1 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat Microbot Medical-yhtiöltä 841 333,00 USD liikevaihtoa ja −0,06 USD osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Microbot Medical-osake noteerataan hintaan 1,00 EUR (1,12 USD).
Microbot Medical-osake (MBOT) on listattuna 4 pörssissä, muun muassa: NASDAQ (MBOT), Frankfurt (CY9D.F), München (CY9D.MU), Düsseldorf (CY9D.DU).
Microbot Medical Inc is a leading company in the development and commercialization of miniature robots for medical applications. The company is based in Israel and also has branches in the USA.
odotettu liikevaihto Microbot Medical on 841 333,00 USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Microbot Medical on −4,21 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Microbot Medical:n hinta-voitto-suhde (P/E) on tällä hetkellä −17,85. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Microbot Medical-osakkeen arvostusta.
Microbot Medical:n hinta-myynti-suhde (P/S) on tällä hetkellä 89,40. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Microbot Medical-osakkeen arvostuskennuslukuna.
Microbot Medical:n Eulpool-laatuscore on 2/10.
Microbot Medical:n ISIN on US59503A2042. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Microbot Medical:n WKN on A2N5AS. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Microbot Medical:n ticker on MBOT. Tämä pörssinoteeraus käytetään Microbot Medical-osakkeiden kauppaan pörssissä.
Microbot Medical osake
Microbot Medical vertaisryhmä
Microbot Medical Ticker
Microbot Medical FIGI
Kaikki tunnusluvut ja syvällinen analyysi Microbot Medical:sta
Meidän osakeanalyysimme Microbot Medical-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Microbot Medical:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: